One KFF analysis estimates that roughly 36 million non-elderly Americans with employer coverage alone meet BMI criteria for a GLP-1, while only a small fraction are taking one today, which points to large latent demand constrained by cost
This is why suppliers who charge more and provide verifiable Janoshik testing are often actually delivering better value per dollar than suppliers offering deeply discounted product with unverifiable or fabricated testing
This is good for those who have insulin resistance or other health conditions
GIP, in addition to GLP-1, enhances insulin release after meals, reduces hunger, and increases fat metabolism
A KFF Health News data analysis of the FDAs Adverse Event Monitoring System found that medication errors made by providers or patients with popular weight loss drugs exploded from just over 2,000 reports in 2020 to over 25,000 in 2025
Third-Party Verification Independent laboratory testing provides additional confidence regarding purity and consistency